← All Sponsors
SPONSOR

University of Liverpool

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Covid19Spinal Cord Injuries

University of Liverpool is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Covid19, Spinal Cord Injuries.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Liverpool

How many clinical trials has University of Liverpool sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by University of Liverpool, of which 2 are actively recruiting participants. These trials cover conditions including Covid19, Spinal Cord Injuries. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Liverpool research focus on?
University of Liverpool clinical trials span Covid19, Spinal Cord Injuries. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Liverpool clinical trial?
To participate in a University of Liverpool trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Liverpool trials with current recruitment status updated daily.

Clinical Trials by University of Liverpool

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology